What do we know about the mechanisms of aromatase inhibitor resistance?
- 31 December 2006
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 102 (1-5), 232-240
- https://doi.org/10.1016/j.jsbmb.2006.09.012
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersBreast Cancer Research and Treatment, 2006
- Role of Androgens on MCF-7 Breast Cancer Cell Growth and on the Inhibitory Effect of LetrozoleCancer Research, 2006
- Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancerEndocrine-Related Cancer, 2005
- Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivityEndocrine-Related Cancer, 2005
- The Role of Growth Factor Receptor Pathways in Human Breast Cancer Cells Adapted to Long-term Estrogen DeprivationCancer Research, 2005
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell PhenotypeEndocrinology, 2003
- Enhanced Estrogen Receptor (ER) α, ERBB2, and MAPK Signal Transduction Pathways Operate during the Adaptation of MCF-7 Cells to Long Term Estrogen DeprivationJournal of Biological Chemistry, 2003
- Endocrine-responsive breast cancer and strategies for combating resistanceNature Reviews Cancer, 2002
- Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal womenEuropean Journal of Cancer and Clinical Oncology, 1986